MicroBase Technology

MicroBase Technology Deferred Tax Liabilities

The Deferred Tax Liabilities of MicroBase Technology (3184.TWO) as of Oct 22, 2026 is 2.45 M TWD. In the previous year, Deferred Tax Liabilities was 848,000.00 TWD — a change of 189.27% (higher).

Deferred Tax Liabilities

2.45 MTWD

YoY

189.27%

Last updated:

Deferred Tax Liabilities of MicroBase Technology is 2024 2.45 M TWD. Deferred Tax Liabilities of MicroBase Technology was 2023 848,000.00 TWD. It decreases by 189.27% higher compared to the previous year.

The MicroBase Technology Deferred Tax Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Deferred Tax Liabilities
Date
Deferred Tax Liabilities
Jan 1, 2017
143,000.00 TWD
Jan 1, 2018
130,000.00 TWD
Jan 1, 2019
94,000.00 TWD
Jan 1, 2020
1.01 M TWD
Jan 1, 2021
693,000.00 TWD
Jan 1, 2022
3.98 M TWD
Jan 1, 2023
848,000.00 TWD
Jan 1, 2024
2.45 M TWD
The MicroBase Technology Deferred Tax Liabilities history
YEARDeferred Tax LiabilitiesYoY
2.45 MTWD+189.27%
848,000.00TWD-78.67%
3.98 MTWD+473.74%
693,000.00TWD-31.11%
1.01 MTWD+970.21%
94,000.00TWD-27.69%
130,000.00TWD-9.09%
143,000.00TWD+55.43%
92,000.00TWD-65.67%
268,000.00TWD+25.23%
214,000.00TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

MicroBase Technology Stock analysis

What does MicroBase Technology do? MicroBase Technology Corp, listed on the Taiwan Stock Exchange under ticker 3184.TWO, is a health care company headquartered in Taoyuan, Taiwan. The company has 48 employees and completed its initial public offering on April 18, 2013. MicroBase Technology Corp engages in the production, planning, and maintenance of medical equipment. The company's product portfolio includes the Inkjet Printer Nozzle Plate, Microneedle Patch, Aerosol Generator Head, Nebulizer, and Soft Mist Inhaler, among others. These products are distributed both domestically within Taiwan and internationally to overseas markets. The company operates within the health care sector, focusing on medical equipment solutions. MicroBase Technology Corp maintains a website at https://microbasetech.com/ for further information. The company's operations are centered around the development and distribution of specialized medical devices, with an emphasis on both local and global market reach. As a publicly traded entity, it provides transparency through its financial disclosures and corporate governance practices. The firm's activities are primarily conducted in Taoyuan, Taiwan, reflecting its regional operational base. MicroBase Technology Corp's business model involves the manufacturing and maintenance of medical equipment, targeting both domestic and international customers through its product offerings. MicroBase Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MicroBase Technology stock

Deferred Tax Liabilities of MicroBase Technology is 2.45 M TWD in 2024.

Deferred Tax Liabilities of MicroBase Technology changed from 848,000.00 TWD to 2.45 M TWD, representing a 189.27% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Deferred Tax Liabilities MicroBase Technology since 2006 – with annual values, charts, and detailed analysis.

Deferred tax liabilities arise from temporary differences between accounting and tax treatments. They represent taxes owed in the future on income already recognized.

Deferred Tax Liabilities's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Deferred Tax Liabilities's MicroBase Technology historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — MicroBase Technology

All Key Metrics — MicroBase Technology